25 May 2013
Keywords: Merck & Co, Zioptan, USA, FDA, Ophthalmic solution, Glaucoma, Saflutan
Article | 14 February 2012
The US Food and Drug Administration) has approved drug giant Merck & Co’s (NYSE: MRK) Zioptan (tafluprost ophthalmic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 February 2012
24 May 2013
© 2013 thepharmaletter.com